Boone Capital Management »

Cogent Biosciences shares owned by Boone Capital Management

Quarter-by-quarter ownership of Cogent Biosciences (COGT) shares owned by Boone Capital Management from 13F filings

Historical chart of Boone Capital Management investment in Cogent Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Cogent Biosciences held by Boone Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cogent Biosciences by Boone Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $14M 945k 14.36

More positions owned by Boone Capital Management

Medtronic SHS (MDT)
Mirum Pharmaceuticals (MIRM)
Ionis Pharmaceuticals (IONS)
Cigna Corp (CI)
Bridgebio Pharma (BBIO)
Neurocrine Biosciences (NBIX)
Rapt Therapeutics Com New (RAPT)
UnitedHealth (UNH)
BioMarin Pharmaceutical (BMRN)
Icon SHS (ICLR)
Cogent Biosciences (COGT)
Kodiak Sciences (KOD)
Livanova SHS (LIVN)
Uniqure Nv SHS (QURE)
Clearpoint Neuro (CLPT)

View all positions for Boone Capital Management

Top funds holding Cogent Biosciences

FMR
BlackRock
Deerfield Management Company
Fairmount Funds Management
Kynam Capital Management
Vanguard Group
Commodore Capital
TCG Crossover Management
State Street Corporation
VR Adviser
Rtw Investments
Geode Capital Management
Henderson Group
Paradigm Biocapital Advisors
Octagon Capital Advisors

View all funds holding Cogent Biosciences